Newly-released Buttock Augmentation Market analysis report by Future Market Insights shows that global sales of the Buttock Augmentation Market in 2021 were held at US$ 1.9 Billion. With a CAGR of 27.4% from 2022 to 2032, the market is projected to reach a valuation of US$ 26.9 Billion. Buttock Implants is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 29.5% from 2022 to 2032.
| Attribute | Details |
|---|---|
| Global Buttock Augmentation Market (2022) | US$ 2.4 Billion |
| Global Buttock Augmentation Market (2032) | US$ 26.9 Billion |
| Global Buttock Augmentation Market CAGR (2022 to 2032) | 27.4% |
| USA Buttock Augmentation Market CAGR (2022 to 2032) | 28.8% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Buttock Augmentation Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2015 to 2021, the market value increased at around 23% CAGR.
Buttock implants are silicone implants that are inserted between the buttock cheeks and put in the buttocks. However, buttock injections, which are minimally invasive and gaining favor among individuals, are also accessible.
Buttock augmentation is assumed as one of the most popular types of plastic surgery. Furthermore, buttock augmentation operations such as buttock lifts and fat grafting are the most common buttock augmentation procedures.
Increased appearance conscientiousness, increased disposable income, and strong social media influence, in the field of aesthetics, are the key factors that are leading to market growth.
With the increase in disposable income of the public and the expansion of the medical tourism business in emerging countries, the healthcare industry in emerging economies is growing at a rapid pace. In addition, the market is projected to expand as the increase in the incidence of buttock disorders is attributed to the aging population. Culture too plays an important role in the demand for Buttock Augmentation. For example, in Asia curvature as well as sufficient volume and muscles define a “beautiful buttock”.
The procedures of fat grafting are known as the most effective and are associated with high satisfaction, as well as very low inconveniences and risks. This is projected to drive the market in the coming years. Moreover, technological advancements and enhancements in existing silicone buttock implants for buttock augmentation and reconstruction will propel the industry forward.
Increased consumer awareness about cosmetic operations, innovations in implants, fewer side effects, and a higher success rate of buttock augmentation treatment are the key factors driving the global buttock augmentation industry.
Many countries around the world have experienced significant urbanization, and per capita wealth has surged in many developing regions, leading to people spending their money on aesthetic operations. Hyaluronic or silicone gel injections are being explored as non-invasive treatments for the operation. Post their success, the augmentation market will have a significant possibility to grow in the future years.
On the other hand, the high cost of treatment and adverse effects associated with buttock augmentation surgery, such as infection, implant migration, bleeding, and poor wound healing, are limiting the global market's growth.
Principal Consultant
Physical appearance consciousness is growing, as is knowledge of various beauty care products and procedures available globally, resulting in aesthetic consciousness among the people and therefore market growth. Adding to it, when it comes to purchasing cosmetic products, social media plays a significant part in influencing millennial purchasing decisions, and peer recommendations are quite important.
Moreover, with the aging population, cases of buttock abnormalities are also on the rise, which is leading to an increase in the demand for buttock augmentation.
In 2021, North America held the largest share of the global Buttock Augmentation Market. This is attributed to the high aesthetic awareness, and people opting for cosmetic producers. Furthermore, technological advancements and a huge cosmetic professional pool are also leading to a surge in the market in North America.
In Asia Pacific, the market is expected to increase at a forecasted CAGR of more than 29%. Advancements in urbanization can be largely credited to the increasing use of social media, the availability of low-cost surface procedures, and top-notch surgical procedures.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The United States is expected to account for the largest market of US$ 11.1 Billion by the end of 2032, growing at a projected CAGR of 28.8%. The abundance of highly skilled cosmetic professionals, the advancement in technology, and the prevalent minimally invasive practices are leading to market growth in the United States. The population here too, is increasingly aware of physical appearance and the availability of the means to enhance it, which acts as a booster to the demand for buttock augmentation in the United States.
The market in the U.K. is expected to reach a valuation of US$ 1.2 Billion by 2032. Growing at a CAGR of 29.8% from 2022 to 2032, the market in the country is expected to gross US$ 1.1 Billion.
The market in Japan is projected to reach US$ 1.1 Billion by 2032. With a CAGR of 29.3% during the forecast period, the market is likely to garner an absolute dollar opportunity of US$ 1 Billion.
The market in South Korea is expected to reach US$ 511 Million by 2032 at a CAGR of 26.3% from 2022 to 2032. During this period, the market is expected to garner an absolute dollar opportunity of US$ 460.9 Million.
The Buttock Implants segment has historically grown at a CAGR of 24.2% between 2015 to 2021 and is forecasted to grow at the highest CAGR of over 29.5% from 2022 to 2032. This is mainly because of the higher demand for the techniques like fat grafting and butt lift which have faster post-operative healing.
Aesthetic Clinics commanded the largest revenue as well as CAGR of nearly 25.4%, during the forecast period. Aesthetic clinics are becoming increasingly popular because of enhanced service quality, individualized customer attention, and reduced treatment costs than other venues. Aesthetic clinics not only treat cosmetic concerns of the skin, hair, body, and face, but they also provide conventional spa and beauty services, such as haircutting, manicures, dentistry, and the removal of skin tags, warts, moles, freckles, and birthmarks, among other things. This explains the growth of the global market through aesthetic clinics.
Until the end of the forecast period, the demand through Hospitals will have a considerable market share in the global buttock augmentation market. Hospitals in many rich and developing countries are well-equipped with high-end devices that utilize cutting-edge technology due to their strong infrastructure. Hospitals are connected with a high number of qualified practitioners in the field of aesthetic operations as they give all of the required facilities to carry out such treatments.
Various specialized hospitals have formed partnerships with reputable manufacturers and have submitted tenders for the procurement of innovative aesthetic devices, indicating that the industry will continue to grow in the future years.
The key players operating in the buttock augmentation market include Sientra Inc., Polytech Health & Aesthetics, Allergan, Hospital Corporation of America, Implantech, Dermax Technology Ltd., and Sebbin.
Some of the recent developments of key Buttock Augmentation providers are as follows:
Similarly, recent developments related to companies in the Buttock Augmentation market have been tracked by the team at Future Market Insights, which are available in the full report.
The global market is worth more than US$ 1.9 Bn at present.
The market value is projected to increase at a CAGR of around 27.4% from 2022 to 2032.
The market value increased at a CAGR of around 23% from 2015 to 2021.
Increased appearance conscientiousness, strong social media influence, increased disposable income, and technological improvement in the field of aesthetics is bolstering the growth.
The market for Buttock Augmentation Market in China is projected to expand at a CAGR of around 29.2% from 2022 to 2032.
While the market in South Korea is expected to grow at nearly 26.3%, the market in Japan is projected to register a CAGR of nearly 29.3% from 2022 to 2032.
1. Executive Summary | Buttock Augmentation Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Regulatory Landscape
3.3.1. By Key Regions
3.3.2. By Key Countries
3.4. Regional Parent Market Outlook
3.5. Production and Consumption Statistics
3.6. Import and Export Statistics
4. Global Market Analysis 2015 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2015 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2015 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032
5.3.1. Buttock Injections
5.3.1.1. Hydrogel Butt Injections
5.3.1.2. PMMA Butt Injections
5.3.1.3. Poly-L-lactic acid
5.3.1.4. Silicone Butt Injections
5.3.2. Buttock Implants
5.3.2.1. Silicone Gel implants
5.3.2.2. Fat grafting
5.3.3. Other Product Types
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2015 to 2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032
6. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By End Use
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End Use, 2015 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Use, 2022 to 2032
6.3.1. Hospitals
6.3.2. Aesthetic Clinics
6.3.3. Other End-uses
6.4. Y-o-Y Growth Trend Analysis By End Use, 2015 to 2021
6.5. Absolute $ Opportunity Analysis By End Use, 2022 to 2032
7. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2015 to 2021
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. East Asia
7.3.5. South Asia
7.3.6. Oceania
7.3.7. Middle East & Africa (MEA)
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. The US
8.2.1.2. Canada
8.2.2. By Product Type
8.2.3. By End Use
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By End Use
8.4. Key Takeaways
9. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Argentina
9.2.1.4. Rest of Latin America
9.2.2. By Product Type
9.2.3. By End Use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By End Use
9.4. Key Takeaways
10. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. Italy
10.2.1.3. France
10.2.1.4. The UK
10.2.1.5. Spain
10.2.1.6. Russia
10.2.1.7. BENELUX
10.2.1.8. Rest of Europe
10.2.2. By Product Type
10.2.3. By End Use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By End Use
10.4. Key Takeaways
11. East Asia Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.2. By Product Type
11.2.3. By End Use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By End Use
11.4. Key Takeaways
12. South Asia Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Thailand
12.2.1.3. Malaysia
12.2.1.4. Indonesia
12.2.1.5. Rest of South Asia
12.2.2. By Product Type
12.2.3. By End Use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By End Use
12.4. Key Takeaways
13. Oceania Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Product Type
13.2.3. By End Use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By End Use
13.4. Key Takeaways
14. MEA Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
14.2.1. By Country
14.2.1.1. GCC
14.2.1.2. Rest of MEA
14.2.2. By Product Type
14.2.3. By End Use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By End Use
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. The US
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Product Type
15.1.2.2. By End Use
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Product Type
15.2.2.2. By End Use
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Product Type
15.3.2.2. By End Use
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Product Type
15.4.2.2. By End Use
15.5. Argentina
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Product Type
15.5.2.2. By End Use
15.6. Germany
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Product Type
15.6.2.2. By End Use
15.7. Italy
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Product Type
15.7.2.2. By End Use
15.8. France
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Product Type
15.8.2.2. By End Use
15.9. The UK
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Product Type
15.9.2.2. By End Use
15.10. Spain
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Product Type
15.10.2.2. By End Use
15.11. Russia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Product Type
15.11.2.2. By End Use
15.12. BENELUX
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Product Type
15.12.2.2. By End Use
15.13. China
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Product Type
15.13.2.2. By End Use
15.14. Japan
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Product Type
15.14.2.2. By End Use
15.15. South Korea
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Product Type
15.15.2.2. By End Use
15.16. India
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Product Type
15.16.2.2. By End Use
15.17. Thailand
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Product Type
15.17.2.2. By End Use
15.18. Malaysia
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Product Type
15.18.2.2. By End Use
15.19. Indonesia
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Product Type
15.19.2.2. By End Use
15.20. Australia
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Product Type
15.20.2.2. By End Use
15.21. New Zealand
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2021
15.21.2.1. By Product Type
15.21.2.2. By End Use
15.22. GCC Countries
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2021
15.22.2.1. By Product Type
15.22.2.2. By End Use
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product Type
16.3.3. By End Use
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Spark Therapeutics, Inc.
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments (Product / Age / Sales Channel / Region)
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Bluebird Bio, Inc.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments (Product / Age / Sales Channel / Region)
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Novartis AG
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments (Product / Age / Sales Channel / Region)
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. UniQure N.V.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments (Product / Age / Sales Channel / Region)
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Celgene Corporation
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments (Product / Age / Sales Channel / Region)
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Gilead Lifesciences, Inc.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments (Product / Age / Sales Channel / Region)
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Kolon TissueGene, Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments (Product / Age / Sales Channel / Region)
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. JCR Pharmaceuticals Co., Ltd.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments (Product / Age / Sales Channel / Region)
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. MEDIPOST
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments (Product / Age / Sales Channel / Region)
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Vericel Corporation
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments (Product / Age / Sales Channel / Region)
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. PHARMICELL Co., Ltd
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments (Product / Age / Sales Channel / Region)
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. Organogenesis Inc.
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments (Product / Age / Sales Channel / Region)
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Buttock Augmentation Market
